A controlled substance inventory is the formal, dated record a DEA registrant keeps of every Schedule I–V substance on hand at a specific point in time. For research labs, this isn’t optional paperwork: it’s a federal recordkeeping obligation under the Controlled Substances Act, and it’s one of the first things a DEA diversion investigator or institutional auditor asks to see. This guide covers who has to keep one, what the biennial inventory actually requires, how to build a compliant inventory log, and where researchers commonly go wrong.
Who has to take a controlled substance inventory
Anyone registered with the DEA to handle controlled substances — individually or through an institutional registration — must take an inventory. In a research setting that typically means:
- Principal investigators holding their own DEA registration for Schedule I research (Schedule I substances have no accepted medical use, so research access requires a registration specific to that research protocol).
- PIs or labs operating under an institutional DEA registration that covers Schedule II–V substances used in animal studies, pharmacology, chemistry synthesis, or clinical research.
- Core facilities, vivariums, and pharmacies that store or dispense controlled substances on behalf of multiple research groups.
The inventory requirement attaches to the registration, not to the individual researcher — so if a lab’s DEA registration is institutional, the institution’s research compliance or environmental health & safety (EHS) office is usually the one responsible for coordinating and retaining the inventory, even though lab staff do the physical counting.
Initial inventory vs. biennial inventory
Under 21 CFR 1304.11, every DEA registrant must take two kinds of inventory:
- Initial inventory — taken on the date the registrant first engages in controlled-substance activity (i.e., the first day the lab actually has Schedule I–V material on hand under that registration). A registrant with none on hand at the start still has to record a zero-stock inventory.
- Biennial inventory — a new, complete inventory taken at least once every two years after the initial one. The registrant chooses the anniversary date, but once set, that date becomes fixed going forward unless the registrant formally changes it (and documents the change).
Both inventories carry the same content requirements: they’re taken as of the opening or close of business on the inventory date, and that choice (opening vs. close of business) has to be stated on the record itself, since it determines which day’s transactions are included.
What has to be recorded — exact count vs. estimated count
The level of counting precision required depends on the schedule of the substance:
- Schedule I and II — an exact physical count or measure is required for every substance, every time.
- Schedule III, IV, and V — an estimated count is acceptable, unless the container holds more than 1,000 tablets or capsules, in which case an exact count of that container’s contents is required.
For each substance, the inventory record needs to capture: the name of the substance, its dosage form and strength (where applicable), the quantity in each container, the number of containers of that quantity, and the date and time basis (opening or close of business) of the count. Schedule I and II inventories are also required to be kept separately from Schedule III–V inventories and from all other business records, whether on paper or in an electronic system.
Building a controlled substance inventory log
The DEA does not issue a standard fillable inventory form the way it does for other purposes (DEA Form 222 for Schedule I/II order forms, for example). Registrants and institutions are responsible for creating their own inventory log that satisfies the content requirements above — which is exactly why so many researchers search for a “DEA biennial controlled substance inventory form” and don’t find one: there isn’t an official one to download. A compliant log, whether a spreadsheet, a bound logbook, or a module inside a broader chemical/lab inventory system, generally needs these columns:
| Field | Purpose |
|---|---|
| Substance name & DEA schedule | Identifies what’s being counted and which precision rule applies |
| Dosage form / concentration | Distinguishes, e.g., a stock solution from a diluted working solution |
| Container size & number of containers | Basis for the count, not just a total quantity |
| Quantity per container (exact or estimated) | The actual count, flagged as exact or estimated per the Schedule III–V rule |
| Inventory date & time basis | Opening or close of business on the stated date |
| Location / storage unit | Which locked cabinet, safe, or refrigerator the material was counted in |
| Person taking the count & witness (if institutional policy requires one) | Establishes accountability and supports discrepancy investigations |
Many institutions build the biennial inventory as a formal event — a scheduled date where EHS or the DEA-registered responsible party physically counts every registered storage location in a single pass — rather than relying on a running perpetual log alone. A running log is still useful, and often required by institutional policy, for tracking use between biennial counts, but it doesn’t substitute for the biennial count itself.
Record retention
Under 21 CFR 1304.04, controlled substance records — including inventories — must be kept for at least two years from the date of the record and be readily retrievable for inspection. Many institutions retain them longer than the federal two-year floor, since state pharmacy boards, state controlled-substance authorities, or institutional policy can impose longer retention periods; check your state’s requirements and your institution’s records-retention schedule rather than assuming the federal minimum is sufficient everywhere you operate.
Reconciling discrepancies
An inventory that doesn’t match the running-use log isn’t automatically a violation, but it is a trigger for investigation. Significant loss or theft of a controlled substance — discovered during a biennial count or otherwise — has to be reported to the DEA on DEA Form 106, separately from the routine inventory record. Institutional policy should define what counts as a reportable discrepancy versus normal measurement variance (evaporation, residue, pipetting loss) so lab staff aren’t left guessing in the moment.
Frequently asked questions
How do we properly manage our controlled substance inventory?
In practice, this means three things running together: a perpetual log that’s updated at or near the time of each use (not reconstructed later from memory), a scheduled biennial physical count against that log on a fixed, institution-wide date, and a clear reporting path for discrepancies. The lab and the institutional DEA registration holder (often EHS, research compliance, or a controlled-substances committee) should agree in advance on who counts what, how often interim spot-checks happen, and who signs off on the biennial record.
What is a controlled substance inventory log?
It’s the ongoing record — separate from the formal biennial inventory — that tracks each addition and use of a controlled substance as it happens: date, amount used, remaining balance, and who used it. It’s what makes the biennial physical count reconcilable, since it lets you compare “what the log says should be on hand” against “what’s actually on the shelf.”
Is there an official DEA biennial controlled substance inventory form?
No. The DEA does not publish a standard fillable inventory form. It specifies the required content (21 CFR 1304.11) and lets registrants and institutions design their own log or system, on paper or electronic, as long as it captures that content and meets the recordkeeping and separation requirements.
How often is the biennial inventory required?
At least once every two years, on a date the registrant selects and then keeps fixed going forward (an “annual” cadence is sometimes used voluntarily by institutions that want tighter internal control, but the federal minimum is biennial, not annual).
What are the controlled substance inventory requirements for Schedule III–V substances specifically?
An estimated count is acceptable for Schedule III, IV, and V substances, except that any container holding more than 1,000 tablets or capsules must be counted exactly. Schedule I and II substances always require an exact count, with no estimation allowance.
Related reading
For the broader regulatory framework these requirements sit inside, see 21 CFR: What Title 21 of the Code of Federal Regulations Covers. For documentation practices that pair naturally with inventory logs, see Sample Chain of Custody in Research Labs. For the disposal side of controlled and hazardous lab materials, see Lab Waste Disposal: RCRA Streams, Generator Status, and Disposal Routes.
